Detalles de la búsqueda
1.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Clin Infect Dis;
78(4): 870-879, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37967326
2.
Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa.
Vaccine;
38(4): 897-906, 2020 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708182
3.
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa.
Hum Vaccin Immunother;
15(10): 2386-2398, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012786
4.
Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study.
PLoS One;
12(5): e0177382, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28493930
5.
Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast.
Malar J;
15: 213, 2016 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27075879
Resultados
1 -
5
de 5
1
Próxima >
>>